Andy Hsieh, a biotech analyst at the investment bank William Blair, says his initial reaction upon seeing Novo Nordisks findings was, Oh man
The American Diabetes Association recommends that physicians consider patients to be pre-diabetic if their fasting blood glucose level is above 100mg/dL but less than 125mg/dL and whose glucose levels are at least 140mg/dL but less than 200mg/dL following an oral glucose tolerance test (OGTT)
BPC-157 occupies a separate category altogether: a tissue-targeted compound with intriguing preclinical findings but a much thinner human evidence base and a more complicated regulatory picture
This data can be found here: Ethics statement The studies involving humans were approved by Northwell Health Institutional Review Board
By contrast, with ultrasound, the patient can move, adjust their position, or even take a break, without the restrictions of a claustrophobic tunnel